Molelcular Analysis of Tumor Suppressor Genes, Rb, p53, p16INK4A, p15INK4B and p14ARF in Natural Killer Cell Neoplasms
スポンサーリンク
概要
- 論文の詳細を見る
- 2001-10-31
著者
-
OSHIMI Kazuo
Division of Hematology, Department of Internal Medicine, Juntendo University School of Medicine
-
Oshimi Kazuo
Division Of Hematology Department Of Internal Medicine Juntendo University School Of Medicine
-
Oshimi Kazuo
Division Of Hematology Department Of Medicine Juntendo University School Of Medicine
-
Mori Kiyoshi
Department Of Thoracic Diseases Tochigi Cancer Center
-
Oshimi Kazuo
Department Of Hematology Juntendo University Tokyo
-
Oshimi Kazuo
Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Mori K
Division Of Hematology Department Of Medicine Juntendo University School Of Medicine
-
SAKAJIRI Sakura
Division of Hematology, Department of Medicine, Juntendo University School of Medicine
-
KAWAMATA Norihiko
Division of Hematology, Department of Medicine, Juntendo University School of Medicine
-
EGASHIRA Motoki
Division of Hematology, Department of Medicine, Juntendo University School of Medicine
-
MORI Kiyoshi
Division of Hematology, Department of Medicine, Juntendo University School of Medicine
-
Ohnishi Kazunori
The "lung Injury By Bortezomib" Joint Committee Of The Japanese Society Of Hematology And
-
Kawamata Norihiko
Division Of Hematology Department Of Medicine Juntendo University School Of Medicine
-
Oshimi Kazuo
Division Of Haematology Department Of Internal Medicine Juntendo University School Of Medicine
-
Sakajiri Sakura
Division Of Hematology Department Of Medicine Juntendo University School Of Medicine
-
Egashira M
Juntendo Univ. School Of Medicine Jpn
関連論文
- Serial monitoring of T315I BCR-ABL mutation by Invader assay combined with RT-PCR
- Absence of tumor-specific over-expression of Polo-like kinase 1 (Plk1) in major non-Hodgkin lymphoma and relatively low expression of Plk1 in nasal NK/T cell lymphoma
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Use of Octreotide in the Management of Severe Duodenal Bleeding after Unrelated-Donor Bone Marrow Transplantation
- Molecular monitoring of BAALC expression in patients with CD34-positive acute leukemia
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Lung Cancer in Patients under 50 Years Old
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- Multicenter Prospective Study of Clonal Complications in Adult Aplastic Anemia Patients following Recombinant Human Granulocyte Colony-Stimulating Factor (Lenograstim) Administration
- Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia
- Leukemic infiltration of the lung following allogeneic hematopoietic stem cell transplantation
- Mikulicz's disease with severe thrombocytopenia following autologous stem cell transplantation in a multiple myeloma patient
- Acquired Storage-Pool Disorders Occurring Late After Allogeneic Bone Marrow Transplantation: Partial Activation of Platelets in Asymptomatic Patients
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- COMPARISON AMONG PLASMA NOREPINEPHRINE LEVELS, HEART RATE VARIABILITY, AND MYOCARDIAL IMAGING WITH ^I-METAIODOBENZYLGUANIDINE (MIBG)
- EVALUATION OF CARDIAC ADRENERGIC NEURON ACTIVITY IN CARDIOMYOPATHIC HAMSTER BIO 14.6 AND BIO 53.58 USING I-125 METAIODOBENZYLGUANIDINE (MIBG)
- CARDIAC AUTONOMIC NERVOUS SYSTEM DYSFUNCTION IN PATIENTS WITH CHRONIC RENAL FAILURE ON DIALYSIS
- EFFECTS OF CILAZAPRIL (CLZ) AND VERAPAMIL (VER) IN CARDIOMYOPATHIC HAMSTER BIO 53.58 EVALUATED WITH I-125 METAIODOBENZYLGUANIDINE (MIBG)
- SIMULTANEOUS DUAL MYOCARDIAL IMAGING WITH I-123 BMIPP AND TL-201 IN PATIENTS WITH CORONARY HEART DISEASE
- Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase
- A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease
- A safety, pharmacokinetic and pharmacodynamic investigation of deferasirox (Exjade^【○!R】, ICL670) in patients with transfusion-dependent anemias and iron-overload : a Phase I study in Japan
- True small lymphocytic T-cell chronic lymphocytic leukemia lacking the CD3 molecule and TCR-αβ on its cell surface
- Clinical features of dasatinib-induced large granular lymphocytosis and pleural effusion
- Cystatin C level as a marker of renal function in allogeneic hematopoietic stem cell transplantation
- Frequent Exacerbation of Pulmonary Nocardiosis during Maintenance Antibiotic Therapies in a Hematopoietic Stem Cell Transplant Recipient
- Lung Injury Associated with Bortezomib Therapy in Relapsed/Refractory Multiple Myeloma in Japan : A Questionnaire-Based Report from the "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japanese Society of Clinical
- Immune-Mediated Myelopathy following Allogeneic Stem Cell Transplantation
- Pneumatosis coli after Thalidomide Treatment
- Granulocyte Colony-Stimulating Factor-Primed Donor Lymphocyte Infusion after Salvage Chemotherapy for Treatment of Relapsed Acute Leukemia after Allogeneic Stem Cell Transplantation
- Cytogenetic Abnormalities without Evidence of Relapse after Treatment with Imatinib and Stem Cell Transplantation in a Patient with Ph-Positive ALL
- Molelcular Analysis of Tumor Suppressor Genes, Rb, p53, p16INK4A, p15INK4B and p14ARF in Natural Killer Cell Neoplasms
- A Case of Fungemia due to Candida krusei
- Disseminated Mucor infection and thrombotic microangiopathy in lymphoma-associated hemophagocytic syndrome
- Multiple brain infarctions induced by imatinib mesylate in a patient with clonal eosinophilia
- Molecular Analysis of Oncogenes, ras Family Genes (N-ras, K-ras, H-ras), myc Family Genes (c-myc, N-myc) and mdm2 in Natural Killer Cell Neoplasms
- Epstein-Barr Virus-Positive Hodgkin's Lymphoma in a Patient with Chronic Active Epstein-Barr Virus Infection
- More Than 13 Years of Hypereosinophila Associated With Clonal CD3^-CD4^+ Lymphocytosis of T_H2/T_H0 Type
- SIMULTANEOUS DUAL MYOCARDIAL IMAGING WITH IODINE-123-β-METHYL IODOPHENYL-PENTADECANOIC ACID (BMIPP) AND THALLIUM-201 IN PATIENTS WITH CORONARY HEART DISEASE
- Hepatitis B Virus Reactivation in a Patient With Chronic GVHD After Allogeneic Peripheral Blood Stem Cell Transplantation
- Expression profiles of two types of human knee-joint cartilage
- Imatinib Mesylate (Gleevec) in the Treatment of 2 Patients with Philadelphia-Positive ALL Relapsing after Allogeneic Stem Cell Transplantation
- Successful Unrelated Bone Marrow Transplantation After Arsenic Trioxide Treatment in a Patient With Relapsed Acute Promyelocytic Leukemia
- Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma
- Erythrocytosis caused by erythropoietin-producing thymic carcinoma
- Low-Dose Antithymocyte Globulin for Treatment of Steroid-Pulse-Resistant Acute Graft-versus-Host Disease
- Effect of Additional Chromosomal Abnormalities in Acute Promyelocytic Leukemia Treated With All-trans-Retinoic Acid: A Report of 17 Patients
- Second Allogeneic Peripheral Blood Stem Cell Transplantation With Fludarabine-Based Low-Intensity Conditioning Regimen for Relapsed Myelodysplastic Syndrome After Allogeneic Bone Marrow Transplantation
- Tumor Lysis Syndrome in Widely Metastatic Small-Cell Lung Cancer
- Vasodilator Stress Impairs the Left Ventricular Function Obtained With Gated Single-Photon Emission Computed Tomography in Patients With Known or Suspected Coronary Artery Disease
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases : a multi-institutional study
- Regression of rectal mucosa-associated lymphoid tissue (MALT) lymphoma after antibiotic treatments
- Infant juvenile myelomonocytic leukemia (JMML) with rapid infiltration of multiple organs
- Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T-cell lymphoma (AITL)
- Detection of HTLV-1 by means of HBZ gene in situ hybridization in formalin-fixed and paraffin-embedded tissues
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria : the AEGIS Clinical Trial
- Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase : results from the Japanese subgroup of ENESTnd
- Osteonecrosis of the humeral head
- Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study
- Progressive Respiratory Distress in a Patient with Splenic Marginal Zone Lymphoma
- MeCP2 Expression and Promoter Methylation of Cyclin D1 Gene Are Associated with Cyclin D1 Expression in Developing Rat Epididymal Duct